Company Info
Phone(630) 639-7271
Year Established
2010
Ticker
RARE
Exchange
NASDAQ
Contacts
Erik HarrisCCO
Eric Crombez, M.D.
CMO
Dennis Huang
CTO
Emil D. Kakkis, M.D., Ph.D.
Founder, President & CEO
Karah Parschauer
CLO
Thomas Kassberg
CBO
Howard Horn
CFO & Executive VP, Corporate Strategy
Company Description
Ultragenyx, formerly GeneTx Biotherapeutics, is a biopharmaceutical company committed to bringing to patients novel products for the treatment of serious rare and ultra-rare genetic diseases.